The protein L858R is cited in 293 clinical trials, out of which 233 clinical trials mapped to HPO node “HP:0030358, Non-small cell lung carcinoma,” suggesting a correlation between L858R and Lung Cancer. Here, PROS1 is linked to lung cancer.